Today’s ONXX buyout is yet another biotech acquisition with contingent milestone payments. I think there have been more of these kinds deals in the past 18 months than ever before.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”